- Targeted Therapy Vorasidenib Offers Hope for Deadly Brain Tumors Neuroscience News
- Servier Treatment Breakthrough Cited for an Intractable Brain Cancer The Wall Street Journal
- INDIGO Trial Shows Potential of Vorasidenib in Low-Grade Glioma Targeted Oncology
- Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma | NEJM nejm.org
- Asco 2023 – liver tox casts a pall over Servier’s Indigo readout Evaluate Pharma
- View Full Coverage on Google News
Source: Targeted Therapy Vorasidenib Offers Hope for Deadly Brain Tumors – Neuroscience News
